Abnormally low prolactin levels in schizophrenia patients after switching to aripiprazole in a randomized trial: a biomarker for rebound in psychotic symptoms?

por Jen, Ya-Wen, Hwang, Tzung-Jeng, Chan, Hung-Yu, Hsieh, Ming H., Liu, Chen-Chung, Liu, Chih-Min, Hwu, Hai-Gwo, Kuo, Ching-Hua, Lin, Yi-Ting, Chien, Yi-Ling, Chen, Wei J.
Publicado 2020